Global Nonalcoholic Fatty Liver Disease Sales Market Report Forecast 2017-2021

June 2017 | 110 pages | ID: GDF269E744CEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 NONALCOHOLIC FATTY LIVER DISEASE MARKET OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Nonalcoholic Fatty Liver Disease
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Nonalcoholic Fatty Liver Disease Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Nonalcoholic Fatty Liver Disease (2012-2021)
  1.5.1 Global Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2021)
  1.5.2 Global Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON NONALCOHOLIC FATTY LIVER DISEASE INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURING COST ANALYSIS

3.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL NONALCOHOLIC FATTY LIVER DISEASE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers
  5.1.1 Global Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2012-2017)
5.2 Global Nonalcoholic Fatty Liver Disease (Volume and Value) by Type
  5.5.1 Global Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
  5.5.2 Global Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
5.3 Global Nonalcoholic Fatty Liver Disease (Volume and Value) by Regions
  5.3.1 Global Nonalcoholic Fatty Liver Disease Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Nonalcoholic Fatty Liver Disease Revenue and Market Share by Regions (2012-2017)
5.4 Global Nonalcoholic Fatty Liver Disease (Volume) by Application

6 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

6.1 United States Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  6.1.1 United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  6.1.2 United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  6.1.3 United States Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
6.2 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
6.3 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
6.4 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

7 CHINA NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

7.1 China Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  7.1.1 China Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  7.1.2 China Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  7.1.3 China Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
7.2 China Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
7.3 China Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
7.4 China Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

8 EUROPE NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  8.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  8.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
8.2 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
8.3 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
8.4 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

9 JAPAN NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  9.1.1 Japan Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  9.1.2 Japan Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
9.2 Japan Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
9.3 Japan Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
9.4 Japan Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

10 GLOBAL NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS ANALYSIS

10.1 Conatus Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Daewoong Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Galmed International
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Kyorin Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Metabolic Solutions Development
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Novartis AG
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Phenex Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Raptor Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 TCM Biotech International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL NONALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2017-2021)

13.1 Global Nonalcoholic Fatty Liver Disease Sales, Revenue Forecast (2017-2021)
13.2 Global Nonalcoholic Fatty Liver Disease Sales Forecast by Regions (2017-2021)
13.3 Global Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2017-2021)
13.4 Global Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

FIGURE PICTURE OF NONALCOHOLIC FATTY LIVER DISEASE

Table Classification of Nonalcoholic Fatty Liver Disease
Figure Global Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Applications of Nonalcoholic Fatty Liver Disease
Figure Global Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure China Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Japan Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Global Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2021)
Figure Global Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Table Global Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2012-2017)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table Global Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Global Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales Share by Type (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2012-2017)
Figure Global Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2012-2017)
Figure Global Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales and Market Share by Regions (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales Share by Regions (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Regions (2012-2017)
Figure Global Nonalcoholic Fatty Liver Disease Sales Growth Rate by Regions (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Revenue and Market Share by Regions (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Regions (2012-2017)
Figure Global Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Regions (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2012-2017)
Table Global Nonalcoholic Fatty Liver Disease Sales Share by Application (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2012-2017)
Figure Global Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure United States Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table United States Nonalcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure China Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure China Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure China Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table China Nonalcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Europe Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure Japan Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Japan Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Japan Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table Japan Nonalcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Nonalcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Global Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Global Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Table Global Nonalcoholic Fatty Liver Disease Sales Forecast by Regions (2017-2021)
Table Global Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2017-2021)
Table Global Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2017-2021)